May 2015

CyMedica Orthopedics, Inc.,  has commercially launched the CyMedica QB1 System for the treatment of quadriceps muscle atrophy. The CyMedica QB1 System has introduced at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine (AANA) annual meeting in Los Angeles recently.

Biocon, a leading innovation-led bio-pharmaceutical company, has announced satisfactory financial performance during the fourth quarter ended March 2014. Its consolidated net profit, after exceptional income of Rs. 105 crore on account of sale of Syngene shares, increased by 78.2 per cent to Rs. 201.54 crore from Rs. 113.08 crore in the corresponding period of last year. Operating profit jumped 4.7 percent year-on-year to Rs 202 crore for the quarter ended March 2015 from Rs 193 crore in the same quarter last year.Profit before tax and exceptional income also improved by only 4 per cent to Rs. 143.54 crore from Rs. 138.06 crore. EPS moved up to Rs. 10.08 from Rs. 5.76 crore.  Its consolidated net sales increased by 14.9 per cent to Rs. 830.38 crore during the fourth quarter from Rs. 722.59 crore in the same period of last year. Its pharma sales increased by 10.8 per cent to Rs. 594.91 crore from Rs. 536.77 crore and that of contract research & manufacturing services improved by 27.7 per cent to Rs. 248.92 crore from Rs. 194.90 crore.

In Maharashtra doctors demanding for simplification of F-Form of Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act. Filling-up of F-Form a tedious and lengthy job. F-Form is an important document for maintaining the record in case of prenatal diagnostic test/procedure by genetic clinic/ultrasound clinic and imaging centre.